DURECT Corp reports results for the quarter ended June 30 - Earnings Summary

• DURECT Corp DRRX.OQ reported a quarterly adjusted loss of 7 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -12 cents. The mean expectation of two analysts for the quarter was for a loss of 12 cents per share. Wall Street expected results to range from -13 cents to -11 cents per share.

• Revenue fell 79.4% to $447.00 thousand from a year ago; analysts expected $310.00 thousand.

• DURECT Corp's reported EPS for the quarter was a loss of 7 cents​.

• The company reported a quarterly loss of $2.27 million.

• DURECT Corp shares had risen by 194.4% this quarter and gained 149.3% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 2.7% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is "buy."

• Wall Street's median 12-month price target for DURECT Corp is $2.50, about 25.2% above its last closing price of $1.87

This summary was machine generated from LSEG data August 12 at 08:58 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)